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Bile acids, important mediators of lipid absorption, also act as hormone-like regulators
and as antimicrobial molecules. In all these functions their potency is modulated
by a variety of chemical modifications catalyzed by bacteria of the healthy gut
microbiota, generating a complex variety of secondary bile acids. Intestinal commensal
organisms are well-adapted to normal concentrations of bile acids in the gut. In
contrast, physiological concentrations of the various intestinal bile acid species play
an important role in the resistance to intestinal colonization by pathogens such as
Clostridium difficile. Antibiotic therapy can perturb the gut microbiota and thereby
impair the production of protective secondary bile acids. The most important bile
acid transformation is 7α-dehydroxylation, producing deoxycholic acid (DCA) and
lithocholic acid (LCA). The enzymatic pathway carrying out 7α-dehydroxylation is
restricted to a narrow phylogenetic group of commensal bacteria, the best-characterized
of which is Clostridium scindens. Like many other intestinal commensal species, 7-
dehydroxylating bacteria are understudied in vivo. Conventional animals contain variable
and uncharacterized indigenous 7α-dehydroxylating organisms that cannot be selectively
removed, making controlled colonization with a specific strain in the context of an
undisturbed microbiota unfeasible. In the present study, we used a recently established,
standardized gnotobiotic mouse model that is stably associated with a simplified
murine 12-species “oligo-mouse microbiota” (Oligo-MM12). It is representative of the
major murine intestinal bacterial phyla, but is deficient for 7α-dehydroxylation. We find
that the Oligo-MM12 consortium carries out bile acid deconjugation, a prerequisite
for 7α-dehydroxylation, and confers no resistance to C. difficile infection (CDI).
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Amendment of Oligo-MM12 with C. scindens normalized the large intestinal bile acid
composition by reconstituting 7α-dehydroxylation. These changes had only minor
effects on the composition of the native Oligo-MM12, but significantly decreased early
large intestinal C. difficile colonization and pathogenesis. The delayed pathogenesis
of C. difficile in C. scindens-colonized mice was associated with breakdown of cecal
microbial bile acid transformation.
Keywords: 7α-dehydroxylation, Clostridium scindens, Clostridium difficile, gnotobiotic mouse model, secondary
bile acids, gut microbiota, Clostridium difficile infection (CDI), intestinal infection
INTRODUCTION
Bile acids are biologically important cholesterol derivatives
produced in the liver and secreted into the bile as glycine-
or taurine-conjugated primary bile acids (Chiang, 2009). The
main primary bile acids produced are cholic acid (CA) and
chenodeoxycholic acid (CDCA) in humans, and CA and
muricholic acid (MCA) in mice (Hofmann, 1999; Russell, 2003).
The conjugated forms of these primary bile acids are released
through the bile duct into the duodenum, where they act as
detergents for the emulsification and absorption of dietary lipids
(Hofmann, 2009). Beyond their digestive function, bile acids
also act as hormone-like regulators of host metabolism (Kuipers
et al., 2014) as well as antimicrobials (Begley et al., 2005).
Their potency is influenced by several microbial transformations
during intestinal transit.
In the small intestine, primary bile acids are deconjugated
by bile acid hydrolases which are expressed by a wide variety
of intestinal bacterial taxa including species belonging to the
Bacteroidetes (Narushima et al., 2006), a dominant group
within the gut microbiota. About 95% of the primary bile
acids are reabsorbed in the small intestine and recycled via
the enterohepatic circulation (Russell, 2003; Ridlon et al.,
2005; Hofmann, 2009). The remaining 5% that escape
the enterohepatic circulation undergo further microbial
transformations in the large intestine (Ridlon et al., 2005,
2016). One of the most important bile acid transformations is
7α-dehydroxylation, generating secondary bile acids, including
deoxycholic acid (DCA) and lithocholic acid (LCA). This
multistep biochemical pathway, encoded in the bai (“bile acid
inducible”) gene operon, is restricted to a narrow phylogenetic
group of bacterial species belonging to the Clostridium cluster
XIV and has been most extensively studied in the species
Clostridium scindens and Clostridium hylemonae (Ridlon et al.,
2005, 2016).
Transformation of host-produced conjugated primary
bile acids to DCA and LCA is an example of microbial
inter-species co-metabolism. 7α-dehydroxylation bacteria
depend on other microbial species for deconjugation of the
glycine- or taurine-conjugated bile acids, as they can only
metabolize unconjugated bile acids. For this reason, bile acid
7α-dehydroxylation by human 7α-dehydroxylating species
C. scindens and C. hylemonae cannot occur in mono-colonized
animals, in absence of bile acid deconjugating organisms
(Narushima et al., 1999).
Secondary bile acids play a key role in resistance to intestinal
infection (Begley et al., 2005). The best-studied example is
Clostridium difficile infection (CDI), a nosocomial, antibiotic
therapy-associated diarrheal infection (Rupnik et al., 2009).
Resistance against CDI conferred by a healthy gut microbiota
is abolished when perturbed (dysbiosis) by broad-spectrum
antibiotic treatment (Britton and Young, 2012). The antibiotic-
induced dysbiosis is associated with the abolition of secondary
bile acid biosynthesis in the colon (Antunes et al., 2011; Theriot
et al., 2016, 2014).
It is well-established that bile acids regulate C. difficile
endospore germination and outgrowth as well as vegetative
growth (Wilson et al., 1982; Wilson, 1983). Whilst the
germination receptors of C. difficile are only partially identified
(Francis et al., 2013a; Fimlaid et al., 2015), the primary bile acids
taurocholic acid (TCA) and cholic acid as well as the secondary
bile acid DCA are proven germinants of C. difficile spores
(Sorg and Sonenshein, 2008). Moreover, chenodeoxycholic acid
(CDCA) as well as alpha and beta stereoisomers of muricholic
acid (MCA) are known to inhibit C. difficile germination (Sorg
and Sonenshein, 2010; Francis et al., 2013b). Further, DCA as well
as LCA, ursodeoxycholic acid (UDCA) and ω-muricholic acid
(ω-MCA) are strong inhibitors of spore outgrowth and vegetative
cell growth of C. difficile (Francis et al., 2013b; Weingarden et al.,
2015). Thus, it has been hypothesized that bile acid deconjugating
and 7α-dehydroxylating microbial species play a critical role in
conferring colonization resistance to C. difficile. Initial evidence
supporting this hypothesis was mainly derived from in vitro
experiments; direct evidence for the importance of microbial
bile acid transformation in CDI in vivo is still scarce. Only
recently, Buffie and colleagues, by using metagenomic analyses
and computational modeling of antibiotic-treated animal and
patient samples, were able to infer a strong positive correlation
between the presence of C. scindens-related taxa and CDI
resistance, and successfully tested causality in vivo by inoculation
of antibiotic-treated, CDI-susceptible mice with the C. scindens
type strain ATCC35704 (Buffie et al., 2014).
The intestinal microbiology of C. scindens and related species
is still understudied. A limitation of previous work has been that
C. scindens colonization experiments in vivo required antibiotic-
treated animals containing a dysbiotic microbiota with unclear
background levels of endogenous bile acid 7-dehydroxylating
bacteria. Although this situation mimics the conditions in the
CDI patient, it can be an experimental limitation for the study
of C. scindens physiology in the healthy gut.
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Whilst it is standard to use genetically defined inbred mouse
strains for most experimental animal studies, conventional
animal models contain still rudimentarily defined, and
unstandardized microbial consortia. These consist of hundreds
to thousands of different operational taxonomic units and vary
considerably between individual animals as well as among
research facilities (Rogers et al., 2014; Ericsson et al., 2015; Hoy
et al., 2015). Although modern analytical and computational
tools facilitate the analysis of complex host–microbiota
interactions, it is a challenge to establish the underlying signaling
and metabolic networks without the ability to standardize also
the microbiota composition. Experimental animal models with
a fully standardized microbiota, so-called gnotobiotic animal
models, provide a defined and reduced complexity in vivo system
for the in-depth elucidation of host–microbiota interactions.
In the present study, we used a recently established defined
mouse intestinal microbial consortium, referred to as “oligo-
mouse microbiota” (Oligo-MM12), rationally assembled of 12
mouse-intestinal bacterial isolates representative of the major
mammalian intestinal bacterial phyla (Brugiroux et al., 2016) as
a platform for the in vivo study of C. scindens. The bacterial
strains combined in the Oligo-MM12 consortium were recently
described in detail and are openly available from the DSMZ
repository (Lagkouvardos et al., 2016). Gnotobiotic Oligo-
MM12-associated mice (henceforth referred to as “stable defined
moderately diverse microbiota, murine 2,” short sDMDMm2
mice) were originally generated by colonization of germ-free
mice with a cocktail of cultured bacteria. They have been
stably maintained by breeding under gnotobiotic conditions
for over 25 generations in three independent facilities without
significant compositional deviations, providing mice harboring
a physiologically acquired, and developed stable gut microbiota.
We amended the Oligo-MM12 microbiota by colonization
of gnotobiotic sDMDMm2 mice with C. scindens ATCC35704
and assayed the resulting bile acid 7α-dehydroxylation activity
and protection against CDI in vivo. For this purpose we
first compared the CDI-susceptibility of sDMDMm2 mice with
germ-free and antibiotic treatment mouse models of CDI
and carried out a comprehensive quantitative analysis of the
associated bile acid metabolomes. We then analyzed the effects
of the introduction of C. scindens into the preexisting stable
sDMDMm2 consortium. We show that C. scindens strain
ATCC35704 can be functionally amended to sDMDMm2 to carry
out CA and CDCA 7α-dehydroxylation. In correlation with this
finding, C. scindens colonization specifically delayed intestinal
overgrowth of C. difficile and concomitant intestinal pathology.
Only minor direct effects of C. scindens on the composition of the
12 species of the Oligo-MM12 model consortiumwere detectable.
MATERIALS AND METHODS
Animals and Oligo-MM12 Microbiota
Groups of age matched C57BL/6 mice (6–12 weeks old) were
used. Group sizes used in each experiments are indicated
in the figure legends. Germ-free and gnotobiotic sDMDMm2
mice (Brugiroux et al., 2016) were established and maintained
at the Clean Mouse Facility (CMF) of the Department of
Clinical Research of the University of Bern. sDMDMm2 mice
were colonized with a mouse-intestine derived 12-species
mouse microbiota (Oligo-MM12) consisting of the following
bacterial species: Acutalibacter muris sp. nov. KB18 (DSM
26090), Flavonifractor plautii YL31 (DSM26117), Clostridium
clostridioforme YL32 (DSM 26114), Blautia coccoides YL58 (DSM
26115), Clostridium innocuum I46 (DSM26113), Lactobacillus
reuteri I49 (DSM32035), Enterococcus faecalisKB1 (DSM32036),
Bacteroides caecimuris sp. nov. I48 (DSM 26085), Muribaculum
intestinale sp. nov. YL27 (DSM 28989), Bifidobacterium longum
subsp. animalis YL2 (DSM 26074), Turicimonas muris sp. nov.
YL45 (DSM 26109) and Akkermansia muciniphila YL44 (DSM
26127). All Oligo-MM12 strains are available at http://www.dsmz.
de/miBC. In-depth description of the Oligo-MM12 consortium
species and description of novel taxa are provided elsewhere
(Brugiroux et al., 2016; Lagkouvardos et al., 2016). SPF mice were
purchased from Envigo (formerly Harlan, The Netherlands).
Germ-free and sDMDMm2 mice were exported from flexible
film breeding isolators into sterile individually ventilated cages
(IVC; model Sealsafe Plus, Tecniplast, Italy) for C. difficile
infection experiments. All animal experiments were performed
in accordance with the Swiss Federal and the Bernese Cantonal
regulations and were approved by the Bernese Cantonal ethical
committee for animal experiments under the license number BE
82/13.
Bacterial Strains and Culture Conditions
C. scindens ATCC35704 (Morris et al., 1985) was grown in
BHIS+ medium, which contains 37 g BHI, 5 g yeast extract,
40ml salts solution (0.2 g CaCl2, 0.2 g MgSO4, 1 g K2HPO4,
1 g KH2PO4, 10 g NaHCO3, and 2 g NaCl in 1 L ddH2O), 1 g
L-cysteine and 2 g fructose per L ddH2O or on BHIS+ agar.
Erythromycin (10µg/mL) was added to BHIS+medium to select
for C. scindens ATCC35704 from fecal/cecal samples. C. difficile
DH1916 (Burns et al., 2011) was grown in BHIS medium, BHIS
agar or Clostridium difficile fructose agar (CDFA). Erythromycin
(10µg/mL), cycloserine (0.5mg/mL), cefoxitin (16µg/mL), and
taurocholate (0.1%) were added to plates where necessary.
BHIS+ plates for the enumeration of C. scindens were incubated
in an anaerobic workstation (DonWhitley A45 HEPA, 10% CO2,
10% H2, 80% N2) for 72 h at 37
◦C. CDFA or BHIS plates for the
enumeration of C. difficile were incubated in anaerobic jars using
an atmospheric generator (Genbox anaer, bioMérieux, France)
for 24–48 h at 37◦C or in the anaerobic workstation for 24–48 h
at 37◦C.
Preparation of C. difficile Spores
C. difficileDH1916 was grown overnight in BHIS medium. A 100
µL aliquot of the overnight culture was plated onto BHIS agar
plates and incubated for 5 days in an anaerobic workstation at
37◦C. Plates were removed from the workstation and stored at
4◦C overnight. Using a loop, all cell material was scraped into
1 mL ddH2O (three plates per mL). The spore suspensions were
re-incubated at 4◦C overnight to free spores from mother cells
and subsequently washed for at least 10 times in ice-cold ddH2O.
Spore preps were controlled for their purity using phase contrast
microscopy and spores were enumerated using a hemocytometer
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as well as by plating on BHIS plates containing 0.1% taurocholic
acid. All spore preparations were heat-treated (65◦C, 30 min) to
ensure complete inactivation of any remaining vegetative cells.
All Spore preps were stored at 4◦C until use.
Pretreatments and Infection with C. difficile
SPF mice were antibiotic-pretreated with Clindamycin (100µL
by intraperitoneal injection, 2 mg/mL in PBS) or Streptomycin
(100 µL by gavage, 200 mg/mL in PBS) 24 h before infection.
sDMDMm2 mice were inoculated with C. scindens ATCC35704
by gavage of 109–1010 CFU C. scindens and colonized for 4 or
7 days before C. difficile infection or sacrifice, as specified. C.
scindens pre-colonization was performed in flexible film isolators,
and the mice were subsequently exported into sterile IVCs for
C. difficile infection. C. difficile DH1916 was administered by
gavage of 103 CFU of spores suspended in 100 µL sterile PBS.
Lipocalin-2 Quantification
Lipocalin-2 was measured from terminally collected cecal
content using a commercial ELISA kit (R&D Systems, USA).
The wells of a 96-well plate were coated with lipocalin-2 capture
antibody (1:200 in PBS, 50 µL, incubated at 4◦C overnight),
washed with wash buffer (0.05% Tween-20 in PBS) and blocked
with 150 µL blocking buffer (2% BSA in PBS, 3 h at RT).
The diluted samples (10-fold dilutions over four wells) and
the standards (duplicate, 3-fold dilutions over eight wells)
were applied and the plates were incubated at 4◦C overnight.
After washing with wash solution, 100 µL of biotinylated anti-
lipocalin-2 antibody was applied (1:200 in blocking buffer, 50
µL) and incubated for 1 h at room temperature. The wells
were washed with wash buffer and treated with horseradish-
peroxidase-streptavidin (Biolegend, USA, 1:1000 in PBS, 100µL)
for 1 h at room temperature. Development was performed using
100 µL of substrate buffer (0.1 M NaH2PO4, pH 4.0) with 0.01%
ABTS and 0.1% H2O2. The absorbance at 415 nm was measured
with a plate reader. Standards and samples were fitted using a
non-linear regression and lipocalin-2 values were calculated back
to ng of lipocalin-2 per g of sample.
Histopathology
Cecal tissue was fixed in 4% PFA/PBS immediately after the
sacrifice of the mice and kept at 4◦C for 24 h. The cecum
tissue was rehydrated using a 20% Sucrose/PBS solution at 4◦C
for at least 24 h. The ceca were embedded in Optimal Cutting
Temperature (OCT) medium (Tissue-Tek, Sakura, Japan) and
stored at −80◦C. Sections of 7 µm thickness were cut, air dried
and stained with hematoxylin, and eosin. Cecal histopathology
was evaluated in a blinded manner by a pathologist using an
established scoring system for acute intestinal inflammation
as described (Barthel et al., 2003). Scoring criteria were: (1)
Submucosal edema; 0 = no pathological changes, 1 = mild
edema; the submucosa is <0.20 mm wide, 2 = moderate edema;
the submucosa is 0.21 to 0.45 mm wide, 3 = profound edema;
the submucosa is >0.46 mm wide. (2) Polymorphonuclear
cell (PMN) infiltration into the lamina propria; PMN were
enumerated in 10 high-power fields (400xmagnification in a field
diameter of 420 µm) and the average number of PMN/high-
power field was calculated, 0 ≤ 5 PMN/high-power field, 1 =
5–20 PMN/high-power field, 2= 21–60 PMN/high-power field, 4
≥ 100 PMN/high-power field. (3) Loss of goblet cells; Goblet cells
were enumerated in 10 high-power fields (400x magnification in
a field diameter of 420 µm) of cecum epithelium and the average
of Goblet cells per high-power field was calculated, 1 = 11–28
goblet cells/high-power field, 2 = 1–10 goblet cells/ high-power
field, 3 ≤ 1 goblet cell/ high-power field. (4) Epithelial integrity;
0 = no pathological changes, 1 = epithelial desquamation, 2 =
erosion of the epithelial surface (gaps of 1–10 epithelial cells per
lesion), 3 = epithelial ulceration (gaps of >10 epithelial cells per
lesion). The combined histopathological score was determined as
the sum of these individual scores.
Calprotectin RT-qPCR
To measure the expression of calprotectin, cecal tissue was
taken at the time of necropsy. The cecal tissue was emptied
from all fecal matter, washed in sterile PBS, and immediately
stored in RNAlater (Qiagen, Germany). RNA was extracted from
the tissue using the RNEasy kit (Qiagen, Germany) according
to the manufacturer’s instructions. RNA quality was analyzed
with the Agilent Bioanalyzer system using RNA microchips
(Agilent Technologies, USA). Amplification of calprotectin and
the housekeeping gene β-actin was performed using the following
primers and probes: calprotectin probe (CTC TGC TAC TCC
TTG TGG CTG TCT), calprotectin fw (AGT GTC CTC AGT
TTG TGC AGA), calprotectin rev (CAG GGA CCC AGC CCT
AG), β-actin probe (CCA GTT GGT AAC AAT GCC ATG
TTC), β-actin fw (TAG GCA CCA GGG TGT GAT G), β-
actin rev (TGC CAG ATC TTC TCC ATG TCG). Both probes
were labeled with 6-carboxyfluorescein (FAM) on the 5′ and
the Black hole quencher (BHQ) on the 3′ end. All probes were
synthesized and tested by Microsynth (Switzerland) according to
MIQE guidelines (Bustin et al., 2009). RT-PCR was performed in
duplicates in a volume of 20 µL using the TaqMan RNA to Ct
1-Step kit (Applied Biosystems, USA) on a QuantStudio 7 Flex
Real-Time PCR System (Thermo Fisher, USA) with the following
program: 15 min 48◦C, 10 min 95◦C followed by 40 cycles of 15 s
95◦C, and 1 min 60◦C. Fluorescence was measured for each cycle
after then step of 60◦C. Ct-values for both genes were averaged
over both measurements and the mean Ct of calprotectin was
subtracted from the mean Ct-value of β-actin to normalize.
Bile Acid Extraction
Deuterated CDCA and deoxycholic acid were used as recovery
standards. Approximately 10 milligrams of freeze-dried cecal
content was homogenized with 150 µL of H2O and spiked with
20 µL of recovery standards (100 µM), using an automated
Precellys 24 bead-based homogenizer (5000 rpm; 1 × 20 s).
Mixed samples were equilibrated on ice for 1 h. An amount of
500 µL of ice-cold alkaline (5% ammonia in ACN) was added
to the homogenate, which was then vigorously vortexed, and
continuously shaken for 1 h at room temperature. The mixture
was centrifuged at 16,000 g for 10 min and the supernatant
collected. The pellet was extracted with another 500 µL of ice-
cold alkaline ACN. Supernatants from the two extractions steps
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were pooled and dried in a rotational vacuum concentrator
(Christ, Germany) before reconstitution in 100 µL of 50:50
ammonium acetate (5 mM): methanol (MeOH) pH 6. The
supernatant was kept at−20◦C until LC-MS injection.
UHPLC-HRMS Analyses
Both qualitative and quantitative analyses were conducted on a
Agilent 6530 Accurate-Mass Q-TOF LC/MS mass spectrometer
coupled to an Agilent 1290 series UHPLC system (Agilent
Technologies, USA). The separation was achieved using a Zorbax
Eclipse-Plus C18 column (2.1 × 100 mm, 1.8 µm; Agilent
Technologies, USA) heated at 50◦C. A binary gradient system
consisted of 5 mM ammonium acetate pH 6 in water as eluent A
and acetonitrile as eluent B. The sample separation was carried
out at 0.4 mL/min over a 19 min total run time using the
following program: 0–7 min, isocratic 21% B; 7–7.5 min, 21–
25% B; 7.5–11.5 min, 24–30% B; 11.5–14.5 min, 30–32% B;
14.5–17.5 min, 32–63% B; 17.5–19 min, 63–100% B. The system
was reequilibrated in initial conditions for 2 min. The sample
manager system temperature was maintained at 4◦C and the
injection volume was 0.5 µL. Mass spectrometer detection was
operated in negative ionization mode using the Dual AJS Jet
stream ESI Assembly. The QTOF instrument was operated in the
4 GHz high-resolution mode (typical resolution 17,000 (FWHM)
at m/z 1000) in profile mode and calibrated in negative full scan
mode using ESI-L solution (Agilent Technologies, USA). Internal
calibration was performed during acquisition via continuous
infusion of a reference mass solution [5 mM purine, 1 mM
HP-921 (Agilent reference mass kit, Agilent Technologies USA)
in 95% MeOH acidified with 0.1% formic acid] and allowed
to permanently achieve a mass accuracy better than 5 ppm.
HR mass spectra were acquired over the range of m/z 300–
700 at an acquisition rate of three spectra/s. AJS settings were
as follows: drying gas flow, 8 L/min; drying gas temperature,
300◦C; nebulizer pressure, 35 psi; capillary voltage, 3500 V;
nozzle voltage, 1000 V; fragmentor voltage, 175 V; skimmer
voltage, 65 V; octopole 1 RF voltage, 750 V. Data was processed
using theMassHunterWorkstation (Agilent Technologies, USA).
According to this method, 36 bile acids (Table S1) were quantified
by external calibration curves. Standard stock solutions were
prepared at a concentration of 10 mM in methanol. Bile acid
solutions weremixed together and diluted with 50:50 ammonium
acetate (5 mM):MeOH to construct standard curves between 5
and 5000 nM. Extracted ions chromatograms (XIC) were based
on a retention time (RT) window of ±0.5 min with a mass-
extraction-windows (MEW) of ±30 ppm centered on m/ztheor of
each bile acid.
Quantitative PCR of Bacterial 16S rRNA
Genes
16S rRNA specific primers and hydrolysis probes were designed
using Primer Express 3 (Applied Biosystems, Life Technologies,
USA). For duplex qPCR assays, hydrolysis probes were
5′-labeled with either 6-carboxyfluorescein (FAM) or 6-
carboxyhexafluorescein (HEX). Each probe was conjugated with
the black hole quencher 1 (BHQ1) at the 3′ end. Primers and
probes were synthesized byMetabion (Planegg, Germany). qPCR
conditions were established according to the MIQE guidelines
(Minimum Information for Publication of Quantitative Real-
Time PCR Experiments) (Bustin et al., 2009). All primers were
designed for an optimal annealing temperature of 60◦C. qPCR
standard curves were determined using linearized plasmid as
DNA template. Plasmid DNA was diluted in H2O containing 100
ng/µl yeast tRNA (Roche, Switzerland). Standard curves were
run on a Roche Lightcycler96 instrument in triplicates. Efficiency
of each qPCR reaction was calculated based on the slope of
standard curves (qPCR efficiency: (10(−1/slope of standard curve)−1)
× 100) using 10-fold dilutions of template. Efficiencies for
all qPCR reactions were within the range of 90–110%. For all
experiments the software LightCylcer96 version 1.1 reproduced
standard curves based on single DNA template with known DNA
quantity as well as the efficiency derived from the standard curve
of each qPCR assay of the initial run of the standard curves.
Specificity was confirmed by performing an assay for each
primer/probe pair using an equimolar mixture of all linearized
plasmids except for the one to be tested as template. One PCR
reaction (total volume: 20 µl) contained 300 nM of each primer,
250 nM of the corresponding hydrolysis probe (Table S2),
FastStart Essential DNA Probes Master (Roche, Switzerland),
and 5 ng template gDNA. PCR reactions with DNA templates
extracted from feces or cecal content were run in duplicates. PCR
conditions were: 95◦C for 10 min, followed by 45 cycles of 95◦C
for 15 s, and 60◦C for 1 min. Fluorescence for each cycle was
recorded after the step at 60◦C. Quantification cycle (Cq) as well
as the baseline were automatically determined by the software
LightCycler96 version 1.1 (Roche, Switzerland). The detection
limit ranged between 1 and 248 16S rRNA gene copies/5ng
template gDNA (Table S2).
Statistical Analysis
Statistical analyses were performed as described in Figure
Legends using GraphPad Prism 6 (Version 6.07) or R (Version
3.1.2). Hierarchical clustering in Figures 2, 4 used the dist
function (Canberra distance) as well as the hclust function with
the “complete” method. The NMDS analysis in Figure 5 used the
function metaMDS of the R package vegan as well as the adonis
function for statistical analysis of the differences between groups.
RESULTS
CDI Susceptibility in Microbially Undefined
and Defined Mouse Models
We first addressed the question of whether the sDMDMm2
mice colonized with the 12-species Oligo-MM12 consortium
(Brugiroux et al., 2016), devoid of any known 7-dehydroxylating
microbial activity, at steady-state (without prior antibiotic
treatment) are susceptible or resistant to CDI. We compared
this new model to previously established CDI models including
completely axenic (germ-free) mice (Pawlowski et al., 2010),
antibiotic- (streptomycin- and clindamycin-) pretreated SPF
mice (Buffie et al., 2011; Ng et al., 2013) and unmanipulated
(and highly CDI resistant) SPF mice. All animals were infected
with 103 CFU of C. difficile spores of strain DH1916 (Ribotype
027; Burns et al., 2011) and sacrificed 72 h post infection.
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Quantification of C. difficile in feces at 6 and 24 h post
infection, and in cecal content at 72 h post infection revealed
high C. difficile colonization levels in germ-free, antibiotic-
treated SPF and gnotobiotic sDMDMm2 mice (Figure 1A).
In contrast, unmanipulated SPF animals, apart from the
gastrointestinal transit of the inoculum detected around 6 h
post-infection, showed no evidence for productive intestinal
C. difficile colonization. In all CDI-susceptible mouse models
that we tested, the levels of the intestinal inflammation
markers lipocalin-2 (Figure 1B) and calprotectin (Figure 1C)
were strongly elevated over the background levels measured
in non-infected control mice and the CDI-resistant SPF
mice. Large intestinal histopathology revealed marked mucosal
inflammation in C. difficile-infected germ-free, antibiotic-treated
FIGURE 1 | Infections with C. difficile in sDMDMm2 mice resemble infections in antibiotic-treated mice. Cohorts of germ-free (black circles, n = 6),
sDMDMm2 (red diamonds, n = 5), clindamycin-treated SPF (purple inverted triangles, n = 5), streptomycin-treated SPF (green triangles, n = 5), and SPF control (gray
squares, n = 5) mice were gavaged with 103 CFU C. difficile DH1916 (filled symbols) or PBS vehicle as control (open symbols). (A) Comparison of CFU of C. difficile in
fecal pellets (FP) or cecal contents (CC) at different time points over course of infection. (B) Comparison of lipocalin-2 measured by ELISA in cecal content after 72 h
of infection. (C) Comparison of calprotectin from cecal tissue after 72 h of infection measured by qPCR. Values show the 1Ct derived from measured values of
calprotectin with β-actin as control. (D) Histopathological evaluation of H&E stained sections of cecum tissue at time of necropsy (72 h). Arrows indicate the
representative mice depicted in (E). (E) Representative images of H&E stained sections of cecum tissue at time of necropsy (72 h). L, Lumen; Scale bars: 200 µm.
Statistical analyses in (B–D) used Mann-Whitney-U tests to compare uninfected with infected animals at individual timepoints. Each symbol represents one individual.
Bars indicate medians. Dotted lines indicate lower limit of detection. ns, not statistically significant (p ≥ 0.05); *p < 0.05; **p < 0.01.
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SPF, and gnotobiotic sDMDMm2 animals, but not in the non-
antibiotic-treated SPFmice (Figures 1D,E). Clindamycin-treated
uninfected controls showed an elevated baseline histopathology
of unknown etiology (see Figure 1D) compared to non-
antibiotic-treated SPF mice. In summary, the sDMDMm2 CDI
model is non-colonization-resistant againstC. difficile and closely
reproduces the colonization dynamics and pathogenesis of the
widely used antibiotic-pretreatment mouse models.
Comprehensive Profiling of Bile Acid
Metabolome Associated With Primary and
Antibiotic-Induced CDI Susceptibilities
The available metagenomic information of the Oligo-MM12
consortium (Lagkouvardos et al., 2016) predicts that the Oligo-
MM12 microbiota is able to deconjugate bile acids in vivo,
but that none of the 12 strains harbors the metabolic pathway
for bile acid 7α-dehydroxylation to generate secondary bile
acids. To test this hypothesis and to identify discrete bile acid
metabolome profiles associated with CDI susceptibility in the
different models we carried out targeted UHPLC-HRMS based
metabolomics. Instead of C. difficile inoculation, we sacrificed
cohorts of germ-free, streptomycin-treated SPF, clindamycin-
treated SPF, unmanipulated SPF, and gnotobiotic sDMDMm2
mice and quantified 36 bile acid species (nine of which were
below the minimal detectable concentrations in all samples
and omitted from the analysis; see Figure 2A and Table S1) in
cecum content extracts. An additional group included in this
analysis were sDMDMm2 animals that had been colonized for
7 days with C. scindens, which we hypothesized would increase
the large intestinal concentrations of secondary bile acids
in vivo.
Heat map analysis with unsupervised hierarchical clustering
(Canberra distance) of individual mice based on the quantities
of each bile acid derivative showed distinct bile acid profiles
that grouped the animals according to their experimental
treatment (Figure 2B). Germ-free mice were distinguished from
all microbially colonized groups by the near-complete absence of
deconjugated primary as well as secondary bile acids. Bile acid
deconjugation by bile acid hydrolases is a common intestinal
microbial metabolic activity, and correspondingly absent from
germ-free animals, but evident in all microbially colonized
animal groups tested in this experiment. Both antibiotic-treated
CDI infection models cluster with the untreated SPF animals
but were characterized by an overall reduction of all bile acids,
specifically a marked decrease in secondary bile acids and nearly
undetectable amounts of DCA and LCA in particular. Germ-
free animals, as well as sDMDMm2 + C. scindens and to some
extent the sDMDMm2 gnotobiotes accumulated higher cecal
concentrations of the conjugated primary bile acid TCA than SPF
mice. Similar to the other CDI-susceptible groups, Oligo-MM12-
colonized sDMDMm2 mice lacked most secondary bile acids.
The exception was 7-oxodeoxycholic acid (7-oxoDCA), which
remained at levels equal or higher than found in SPF control
mice. Hence, CDI-susceptible animals were distinguished from
CDI-resistant animals by reduced levels of the six secondary bile
acid species DCA, 12-oxolithocholic acid (12-oxoLCA), LCA,
ursodeoxycholic acid (UDCA), hyodeoxycholic acid (HDCA),
and ωMCA (Figure 2C). Finally, of these six secondary bile acid
species the levels of four, DCA, LCA, UDCA, and 12-oxoLCA
were fully or partially restored to the concentrations found in SPF
control mice by the additional colonization of sDMDMm2 mice
with C. scindens.
Intestinal Colonization of sDMDMm2 Mice
with C. scindens and Bile Acid Profile
Normalization Correlate with Transient
Attenuation of CDI
Next, we analyzed how colonization with C. scindens and the
concomitant changes in secondary bile acid concentrations
correlated with the course of CDI. For this purpose a cohort
of sDMDMm2 mice was infected with C. difficile 4 days after
association with C. scindens. One sub-cohort was sacrificed
24 h after infection (day 5 after C. scindens colonization),
the other 72 h after infection (day 7 after C. scindens
colonization). At the time of sacrifice, we quantified C. scindens
(Figure 3A) and C. difficile densities (Figure 3B), cecal mucosal
pathology (by histopathological scoring, luminal lipocalin-
2 protein, and mucosal calprotectin mRNA quantification;
Figures 3C–F), and cecal luminal bile acid composition (by
UHPLC-HRMS in sDMDM + C. scindens mice; Figure 4).
At the time of infection, C. scindens had reached levels of
108 −109 CFU/g feces (Figure 3A). The C. scindens-associated
mice at 24 h post infection showed partial resistance against
C. difficile colonization compared to controls (Figures 3B–F),
with significantly reduced fecal and cecal C. difficile loads and
absence of marked cecal pathology. This partially protected
phenotype was associated with the presence of secondary bile
acid DCA in the cecal contents (Figures 4A,B, light blue
symbols; reference dataset of uninfected sDMDMm2 mice
colonized with C. scindens for 7 days from Figure 2 is shown
for comparison; orange symbols, indicated by plus sign).
However, we observed a complete loss of protection by 72
h post infection, when large intestinal colonization levels of
C. difficile and cecal pathology were no longer significantly
different from controls (Figures 3B–F). Median C. scindens
densities were decreased at this time point compared to
before infection with C. difficile. The loss of protection was
further associated with a near-complete absence of microbial
bile acid transformation products in cecum contents in these
animals (Figures 4A,B; dark blue symbols). The concentrations
of secondary and primary deconjugated bile acids were near
or below detection limits, very similar to the bile acid profiles
observed in germ-free animals (see Figure 2B). These data show
that colonization with C. scindens impacts the early colonization
dynamics but could not fully prevent C. difficile colonization
and pathogenesis. This is consistent with the previously reported
effects of DCA and LCA in inhibition of vegetative growth
(Sorg and Sonenshein, 2008; Buffie et al., 2014) described
in vitro and ex vivo. The association between CDI-induced
intestinal pathology and the abolition of intestinal microbial
bile acid transformations (deconjugation and 7-dehydroxylation)
to germ-free mouse-like levels prompted us to analyze the
effect of CDI on the large intestinal Oligo-MM12 microbiota
composition.
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FIGURE 2 | Pre-colonization with C. scindens partially restores a SPF-like bile acid profile. SPF mice were pre-treated with streptomycin (n = 4) or
clindamycin (n = 5) 24 h before sacrifice; sDMDMm2 mice pre-colonized 7 days before sacrifice with C. scindens (n = 8), unmanipulated SPF (n = 6), sDMDMm2 (n
= 7), and germ-free (n = 4) animals were used as controls. Cecal content was aseptically removed and processed for bile acid metabolome quantification. Data was
assembled from three individual experiments. (A) Schematic diagram of murine bile acid metabolism. Adapted from Zhang et al. (2012) and Song et al. (2011).
(B) Heatmap analysis constructed from bile acid LC-MS/MS measurements. Values indicate measured bile acid concentrations in µmol/g dry weight of cecal content.
(Continued)
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FIGURE 2 | Continued
(C) Analysis of individual secondary bile acids elevated in sDMDMm2 + C. scindens mice vs. sDMDMm2 mice. Statistical analysis used the Kruskal–Wallis test with
Dunn’s post-test to compare individual bile acids of the different groups against SPF. Each symbol represents one individual. Bars indicate medians. Dotted lines
indicate lower limit of detection. ns, not statistically significant (p ≥ 0.05); *p < 0.05; **p < 0.01; ***p < 0.001. TCA, taurocholic acid; CA, cholic acid; DCA,
deoxycholic acid; 3-dehydroCA, 3-dehydrocholic acid; 7-oxoDCA, 7-oxodeoxycholic acid; 12-oxoLCA, 12-oxolithocholic acid; TDCA, taurodeoxycholic acid; TCDCA,
taurochenodeoxycholic acid; CDCA, chenodeoxycholic acid; LCA, lithocholic acid; UDCA, ursodeoxycholic acid; dehydroLCA, dehydrolithocholic acid; isoLCA,
iso-lithocholic acid; alloLCA, allo-lithocholic acid; 7-oxoLCA, 7-oxolithocholic acid; TUDCA, tauroursodeoxycholic acid; TαMCA, tauro-α-muricholic acid; TβMCA,
tauro-β-muricholic acid; αMCA, α-muricholic acid; βMCA, β-muricholic acid; HCA, hyocholic acid; MDCA, murodeoxycholic acid; 6-oxo-allo-LCA,
6-oxo-allo-lithocholic acid; HDCA, hyodeoxycholic acid; ωMCA, ω-muricholic acid; TωMCA, tauro-ω-muricholic acid; THDCA, taurohyodeoxycholic acid.
Effects of C. scindens and C. difficile
Association on Oligo-MM12 Composition
To analyze the impact of CDI on sDMDMm2 microbiota
composition, sDMDMm2 mice were pre-colonized for 7 days
with C. scindens followed by infection with C. difficile for 72 h
(or uninfected controls). For comparison, we analyzed non-
pretreated sDMDMm2 mice infected with C. difficile for 72 h
(and uninfected controls). We analyzed the bacterial consortium
composition over time in the feces and at the endpoint in
cecal contents using an established 16S rRNA-based TaqMan
qPCR method (see materials and Methods; Brugiroux et al.,
2016) including probes for all Oligo-MM12 species as well as C.
scindens and C. difficile (Figure 5A, Figure S1). We quantified
the fecal (−7 days, −4 days, 0 h, 24 h post infection) as
well as cecal (72 h post infection) Oligo-MM12 composition
C. scindens-associated and non-associated mice to determine
changes in response to C. scindens colonization alone, as well
as in response to C. difficile infection (Figure 5A, Figure S1).
Non-parametric multidimensional scaling (using the metaMDS
function of the vegan package in R) with the qPCR data of the
12 bacterial strains of the Oligo-MM12 microbiota (excluding
the quantities of C. difficile and C. scindens) of all fecal samples
showed that the colonization of sDMDMm2 animals with C.
scindens led to minor changes in Oligo-MM12 composition
(compare yellow and green symbols in Figure 5B). These
changes were mainly driven by variability in the densities of C.
clostridioforme and A. muris sp. nov. (Figure S1) over the time
of the colonization with C. scindens and were not statistically
significant.
As in non-pretreated sDMDMm2 mice, sDMDMm2 +
C. scindens associated mice after 72 h of infection with C.
difficile showed a severely perturbed cecal microbial consortium,
whose species composition differed significantly from uninfected
control animals (Figures 5A,C, p = 0.008 for sDMDMm2; p =
0.001 for sDMDMm2 + C. scindens). Pre-colonization with C.
scindens had no statistically significant influence on this outcome
(Figure 5C, p = 0.145, compare blue and red circles). The
observed shift in microbiota composition was associated with a
decreased density of C. scindens, as well as most of the Oligo-
MM12 bacterial species, reflected in a decreased total bacterial
density (Figure S1).
DISCUSSION
For the presented study we utilized a defined mouse model
associated with a stable low-complexity microbiota that
represents the main phyla of the murine intestinal microbiota.
It has recently been used to study colonization resistance
against the intestinal pathogen Salmonella enterica serovar
Typhimurium (Brugiroux et al., 2016), and for the study
of the metabolism of the facultative intestinal commensal
species E. coli K-12 in the intestinal lumen and mucus layer
(Li et al., 2015). In both examples, it was important for the
microbiological process under study to be tested in context
with a reproducible and defined host–microbial metabolic
background. The host–microbiota background metabolism
was also important in our study: the Oligo-MM12 consortium
carried out primary bile acid deconjugation, a prerequisite for
7α-dehydroxylation.
We detected only minor changes in the Oligo-MM12
microbiota composition following the addition of C. scindens,
including decreases in C. clostridioforme, and A. muris sp. nov.
To what extent these changes are attributable to the increased
concentrations of secondary bile acids or direct competition with
C. scindens remains unknown.
The intestinal bile acid metabolome is closely linked to
the resistance of the gastrointestinal tract against CDI. It has
been shown recently that CDI treatment by fecal microbiota
transplantation therapy not only leads to an increase in gut
microbial diversity, but also reestablishes a bile acid metabolome
that closely mimics that of the stool donor (Weingarden
et al., 2013, 2016). Our data corroborate the association of C.
scindens-produced secondary bile acids DCA and LCA with CDI
resistance in vivo, likely related to inhibition of spore outgrowth
or vegetative growth (see Figure 2; Buffie et al., 2014).
Formal proof of causality of C. scindens-produced secondary
bile acids in inhibition of CDI remains a challenge for as
long as C. scindens and related species cannot be genetically
manipulated. This technical limitation currently prohibits the
study of isogenic bai gene mutants. Thus, we currently
cannot rule out the possibility that the association between
C. scindens colonization and transient inhibition of C. difficile
colonization and pathogenesis is independent of secondary
bile acid production by C. scindens, but rather the result of
other modes of direct or indirect interference between both
species.
In the sDMDMm2 mouse model, C. scindens alone clearly
has only a rather discrete, transient protective effect, but confers
no colonization resistance comparable to that conferred by a
much more diverse SPF microbiota. Full colonization resistance
may require a more diverse microbial consortium including
additional microbial species that compete for nutrients such as
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FIGURE 3 | Addition of C. scindens to sDMDMm2 can partially protect from C. difficile infection. sDMDMm2 animals were pre-colonized by gavage with 109
CFU C. scindens 96 h before infection with 103 CFU C. difficile DH1916 (blue circles). sDMDMm2 animals (red diamonds) served as control. Data is combined from
two independent experiments with endpoints at 24 h (n = 5 sDMDMm2 and n = 5 sDMDM + C. scindens, only data from endpoint shown) and 72 h (n = 6
sDMDMm2 and n = 5 sDMDM + C. scindens). (A) CFU of C. scindens over the course of the infection in pre-colonized mice. (B) Comparison of C. difficile CFU
between sDMDMm2 and sDMDMm2 + C. scindens over the course of infection. Uninfected controls are not depicted. (C) Lipocalin-2 concentration measured by
ELISA in cecal content at 24 and 72 h post infection, respectively. (D) Mucosal calprotectin expression in cecal tissue measured by qPCR at 24 and 72 h post
infection, respectively. Values show the ∆Ct derived from measured values of calprotectin with β-actin as control. (E) Histopathological evaluation of H&E stained
sections of cecum tissue at time of necropsy (24 or 72 h). Uninfected controls are not depicted. Arrows indicate the representative mice depicted in (F). (F) H&E
stained histological sections of cecum sampled at 24 and 72 h post infection. FP, Fecal pellet; CC, Cecal content; L, Lumen; Scale bars: 200 µm. Statistical analyses
in (B–E) used Mann-Whitney-U tests; Each symbol represents one individual. Bars indicate medians. Dotted lines indicate lower limit of detection. ns, not statistically
significant (p ≥ 0.05); *p < 0.05; **p < 0.01.
simple sugars (Ng et al., 2013), metals (Zackular et al., 2016),
or other resources required for intestinal colonization. The
importance of other species has also been demonstrated by the
finding that therapeutic intestinal microbial cocktails may not
need to include 7-dehydroxylating species to be effective (Lawley
et al., 2012).
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FIGURE 4 | Infection of sDMDMm2 + C. scindens mice with C. difficile leads to decrease in secondary and deconjugated primary bile acids. Cecal
contents of sDMDMm2 + C. scindens mice infected with C. difficile used in Figure 3 were used to quantify bile acid measurements. Measurements from uninfected
control mice (colonized with C. scindens for 7 days) from Figure 2 were included as comparison (orange symbols, indicated by plus sign). (A) Heatmap analysis
constructed from bile acid LC-MS/MS measurements. Values indicate measured bile acid concentrations in µmol/g dry weight of cecal content. (B) Analysis of
individual bile acids in sDMDMm2 + C. scindens mice infected by C. difficile over time. Statistical analysis used the Kruskal-Wallis test with Dunn’s post-test to
compare individual bile acids between the groups. Each symbol represents one individual. Bars indicate medians. Dotted lines indicate lower limit of detection. ns, not
statistically significant (p ≥ 0.05); *p < 0.05; **p < 0.01; ***p < 0.001. TCA, taurocholic acid; CA, cholic acid; DCA, deoxycholic acid; 3-dehydroCA, 3-dehydrocholic
acid; 7-oxoDCA, 7-oxodeoxycholic acid; 12-oxoLCA, 12-oxolithocholic acid; TDCA, taurodeoxycholic acid; TCDCA, taurochenodeoxycholic acid; CDCA,
chenodeoxycholic acid; LCA, lithocholic acid; UDCA, ursodeoxycholic acid; dehydroLCA, dehydrolithocholic acid; isoLCA, iso-lithocholic acid; alloLCA, allo-lithocholic
acid; 7-oxoLCA, 7-oxolithocholic acid; TUDCA, tauroursodeoxycholic acid; TαMCA, tauro-α-muricholic acid; TβMCA, tauro-β-muricholic acid; αMCA, α-muricholic
acid; βMCA, β-muricholic acid; HCA, hyocholic acid; MDCA, murodeoxycholic acid; 6-oxo-allo-LCA, 6-oxo-allo-lithocholic acid; HDCA, hyodeoxycholic acid; ωMCA,
ω-muricholic acid; TωMCA, tauro-ω-muricholic acid; THDCA, taurohyodeoxycholic acid.
The analysis of bile acid composition in the C. scindens-
colonized sDMDMm2 mice following 24 and 72 h of infection
revealed that the onset of C. difficile-induced pathology
was associated with the severe disruption of microbiota-
mediated bile acid transformations. Whilst at 24 h post
infection, when the mice were still significantly protected
from the infection, bile acid 7α-dehydroxylation and bile
acid deconjugation were still evident, at 72 h post infection
the bile acid metabolome was reduced to a germ-free-like
status. This was associated with a significant compositional
perturbation of the Oligo-MM12 consortium at 72 h post
infection (Figure 5).
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FIGURE 5 | Addition of C. scindens leads only to small changes in the composition of the Oligo-MM12 microbiota. (A) qPCR based microbiota analysis of
all 12 Oligo-MM strains as well as C. difficile and C. scindens from fecal pellets (−7 days, −4 days, 0 h, 24 h) or cecal content (72 h). Top graph: n = 5 sDMDMm2
and n = 5 sDMDMm2 + C. difficile animals. Bottom Graph: n = 3 sDMDMm2 + C. scindens (pre-colonized for 7 days) and n = 3 sDMDMm2 + C. scindens + C.
difficile animals (pre-colonized for 7 days before infection of 3 days). Y-Axis is depicted as two-segment axis. (B) Non-parametric multidimensional scaling of the
Oligo-MM12 microbiota data shown in (A), analyzed from fecal pellets from time points t = −7 days (before C. scindens colonization), t = −4 days, t = 0 h (before C.
difficile infection), and t = 24 h (without using the qPCR data of C. difficile or C. scindens). (C) Non-parametric multidimensional scaling of the Oligo-MM12 microbiota
data shown in (A), analyzed from cecal contents from timepoint t = 72 h (without using the qPCR data of C. difficile or C. scindens).
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In conventional mice, unlike humans, LCA is only a minor
secondary bile acid species, whereas major murine secondary bile
acids, absent in humans, are the MCA derivatives HDCA, and
ωMCA, which are microbially generated from the primary bile
acids αMCA and βMCA. The mouse-specific primary bile acids
αMCA and βMCA were shown by others to be inhibitors of C.
difficile spore germination and vegetative growth at the relevant
concentrations found in mice (Francis et al., 2013b). However,
in our experiments we could not observe any indication of a
protective effect in GF (harboring increased TβMCA levels) or
sDMDMm2 mice (harboring increased amounts of βMCA) over
the antibiotic-treated mouse models (harboring lower levels of
both compounds).
As reported previously (Sacquet et al., 1984), we found
that, like other 7α-dehydroxylating human isolates, C. scindens
ATCC35704 was unable to transform the mouse-specific primary
MCAs (see Figure 2), whereas murine isolates have been shown
to do so (Eyssen et al., 1999). In keeping with these older
reports, our measurements showed that C. scindens association
did not significantly increase the concentrations of the mouse-
specific secondary bile acids HDCA or ωMCA. There is previous
evidence that links ωMCA to inhibition of germination and
vegetative cell growth of C. difficile (Francis et al., 2013b). This
may have limited the CDI-inhibitory effect of human-derived C.
scindens in the murine system.We hypothesize, that colonization
of sDMDMm2 mice with a mouse-derived 7α-dehydroxylating
bacterium may be able to reestablish a bile acid metabolome that
is even closer to the bile acid metabolome of conventional SPF
mice. Such a more complete bile acid metabolome may confer
higher resistance against CDI inmice, but would not have a direct
correlate in the human system.
In future efforts, the further modular re-constitution of
microbial bile acid transformations in gnotobiotic models will
not necessarily be a mere reductionist approach in comparison
to conventional unstandardized SPF animals. For example, the
human liver, unlike its murine counterpart, is incapable of re-
hydroxylating recirculating secondary bile acids at the seven
position, which in some human individuals can lead to the
accumulation of pathologically elevated levels of DCA and LCA,
associated with enteropathy, and increased colon cancer risk
(Barrasa et al., 2012). The detoxification pathway of DCA and
LCA by epimerization at the three position, generating the 3β-
hydroxy(iso)-bile acids isoDCA and isoLCA, has recently been
elucidated as a novel microbially encoded pathway (Devlin and
Fischbach, 2015). Iso-bile acids are major bile acid species in
some humans but absent in others, and were shown to be
generated by the human commensal bacterium Ruminococcus
gnavus. Although our analysis so far did not include isoDCA,
we did not measure detectable levels of the corresponding LCA
derivative isoLCA in the SPF control mice, suggesting that
commonly used SPF mice (at least from our supplier) may
lack these organisms and therefore the possibility to study this
important detoxification pathway in the mouse model. Thus,
for the study of the human pathological condition associated
with deficiency of this bile acid detoxifying transformation,
a combination of adding a 3-epimerizing bacterial species to
the microbiota and the genetic engineering of the murine
liver metabolism (by knockout of the 7α-rehydroxylation
pathway) could provide a useful disease model that extends the
microbiome repertoire of conventional mice.
The presented work represents a first step toward the
normalization of host–microbial bile acid co-metabolism in a
gnotobiotic mouse model that is well-established (Li et al., 2015;
Brugiroux et al., 2016). The rational amendment of additional
microbial metabolic modules in the future will provide further
refined models for the study of host–microbial interactions using
defined microbial consortia and may pave the way toward better-
standardized animal models.
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